{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T10:00:00Z","timestamp":1793700000423,"version":"4.5.1"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:00:00Z","timestamp":1691020800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","award":["01HD104553"],"award-info":[{"award-number":["01HD104553"]}],"id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","award":["HHSN275201800001I"],"award-info":[{"award-number":["HHSN275201800001I"]}],"id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014461","name":"NIHR Biomedical Research Centre, Royal Marsden NHS Foundation Trust\/Institute of Cancer Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014461","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000085","name":"Ontario HIV Treatment Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000765","name":"University College London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000765","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003784","name":"Great Ormond Street Hospital for Children","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003784","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/j.ebiom.2023.104762","type":"journal-article","created":{"date-parts":[[2023,8,14]],"date-time":"2023-08-14T17:00:26Z","timestamp":1692032426000},"page":"104762","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["Folate deficiency increases the incidence of dolutegravir-associated foetal defects in a mouse pregnancy model"],"prefix":"10.1016","volume":"95","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4132-8363","authenticated-orcid":false,"given":"Haneesha","family":"Mohan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"MacKenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audrey","family":"Yee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn Yukino","family":"Laurette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanvi","family":"Sanghvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Tejada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5702-8344","authenticated-orcid":false,"given":"Valeriya","family":"Dontsova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kit-Yi","family":"Leung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cameron","family":"Goddard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taylor","family":"De Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John G.","family":"Sled","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas D.E.","family":"Greene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J.","family":"Copp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2817-6134","authenticated-orcid":false,"given":"Lena","family":"Serghides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2023.104762_bib1","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1097\/QAD.0000000000001845","article-title":"The transition to dolutegravir and other new antiretrovirals in low-income and middle-income countries: what are the issues?","volume":"32","author":"Vitoria","year":"2018","journal-title":"AIDS"},{"key":"10.1016\/j.ebiom.2023.104762_bib2","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1056\/NEJMc1807653","article-title":"Neural-tube defects with dolutegravir treatment from the time of conception","volume":"379","author":"Zash","year":"2018","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ebiom.2023.104762_bib3","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1056\/NEJMoa1905230","article-title":"Neural-tube defects and antiretroviral treatment regimens in Botswana","volume":"381","author":"Zash","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ebiom.2023.104762_bib4","series-title":"Update on neural tube defects with antiretroviral exposure in the Tsepamo Study","author":"Zash","year":"2022"},{"key":"10.1016\/j.ebiom.2023.104762_bib5","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1056\/NEJMc1908155","article-title":"Dolutegravir use at conception - additional surveillance data from Botswana","volume":"381","author":"Raesima","year":"2019","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ebiom.2023.104762_bib6","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1016\/S2352-3018(20)30268-X","article-title":"Dolutegravir and pregnancy outcomes in women on antiretroviral therapy in Brazil: a retrospective national cohort study","volume":"8","author":"Pereira","year":"2021","journal-title":"Lancet HIV"},{"key":"10.1016\/j.ebiom.2023.104762_bib7","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1111\/1471-0528.15838","article-title":"Congenital anomalies following antenatal exposure to dolutegravir: a Canadian surveillance study","volume":"126","author":"Money","year":"2019","journal-title":"BJOG"},{"key":"10.1016\/j.ebiom.2023.104762_bib8","doi-asserted-by":"crossref","first-page":"S48","DOI":"10.1093\/ofid\/ofab466.074","article-title":"74. Maternal dolutegravir (DTG) use during pregnancy and birth outcomes: the antiretroviral pregnancy registry (APR)","volume":"8","author":"Vannappagari","year":"2021","journal-title":"Open Forum Infect Dis"},{"key":"10.1016\/j.ebiom.2023.104762_bib9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1146\/annurev-neuro-062012-170354","article-title":"Neural tube defects","volume":"37","author":"Greene","year":"2014","journal-title":"Annu Rev Neurosci"},{"key":"10.1016\/j.ebiom.2023.104762_bib10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ejogrb.2004.04.022","article-title":"Risk of drug-induced congenital defects","volume":"117","author":"De Santis","year":"2004","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ebiom.2023.104762_bib11","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1016\/S1474-4422(13)70110-8","article-title":"Neural tube defects: recent advances, unsolved questions, and controversies","volume":"12","author":"Copp","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.ebiom.2023.104762_bib12","doi-asserted-by":"crossref","first-page":"3675","DOI":"10.1093\/hmg\/ddn262","article-title":"Gene-environment interactions in the causation of neural tube defects: folate deficiency increases susceptibility conferred by loss of Pax3 function","volume":"17","author":"Burren","year":"2008","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.ebiom.2023.104762_bib13","first-page":"CD007950","article-title":"Effects and safety of periconceptional oral folate supplementation for preventing birth defects","volume":"2015","author":"De-Regil","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.ebiom.2023.104762_bib14","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/QAD.0000000000002741","article-title":"Unexpected interactions between dolutegravir and folate: randomized trial evidence from South Africa","volume":"35","author":"Chandiwana","year":"2021","journal-title":"AIDS"},{"key":"10.1016\/j.ebiom.2023.104762_bib15","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1124\/dmd.119.087635","article-title":"Clinical extrapolation of the effects of dolutegravir and other HIV integrase inhibitors on folate transport pathways","volume":"47","author":"Zamek-Gliszczynski","year":"2019","journal-title":"Drug Metab Dispos Biol Fate Chem"},{"key":"10.1016\/j.ebiom.2023.104762_bib16","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1097\/QAD.0000000000002289","article-title":"The antagonism of folate receptor by dolutegravir: developmental toxicity reduction by supplemental folic acid","volume":"33","author":"Cabrera","year":"2019","journal-title":"AIDS"},{"key":"10.1016\/j.ebiom.2023.104762_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2021.103771","article-title":"Interaction between dolutegravir and folate transporters and receptor in human and rodent placenta","volume":"75","author":"Gilmore","year":"2022","journal-title":"eBioMedicine"},{"key":"10.1016\/j.ebiom.2023.104762_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2020.103167","article-title":"Dolutegravir in pregnant\u00a0mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels","volume":"63","author":"Mohan","year":"2021","journal-title":"eBioMedicine"},{"key":"10.1016\/j.ebiom.2023.104762_bib19","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1002\/bdra.20632","article-title":"The genetic background of the curly tail strain confers susceptibility to folate-deficiency-induced exencephaly","volume":"88","author":"Burren","year":"2010","journal-title":"Birth Defects Res A Clin Mol Teratol"},{"key":"10.1016\/j.ebiom.2023.104762_bib20","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.antiviral.2018.09.008","article-title":"Improving the clinical relevance of a mouse pregnancy model of antiretroviral toxicity; a pharmacokinetic dosing-optimization study of current HIV antiretroviral regimens","volume":"159","author":"Kala","year":"2018","journal-title":"Antiviral Res"},{"key":"10.1016\/j.ebiom.2023.104762_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0084321","article-title":"Structural stabilization of tissue for embryo phenotyping using micro-CT with iodine staining","volume":"8","author":"Wong","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2023.104762_bib22","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1016\/j.celrep.2017.10.072","article-title":"Partitioning of one-carbon units in folate and methionine metabolism is essential for neural tube closure","volume":"21","author":"Leung","year":"2017","journal-title":"Cell Rep"},{"key":"10.1016\/j.ebiom.2023.104762_bib23","doi-asserted-by":"crossref","first-page":"6388","DOI":"10.1038\/ncomms7388","article-title":"Glycine decarboxylase deficiency causes neural tube defects and features of non-ketotic hyperglycinemia in mice","volume":"6","author":"Pai","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2023.104762_bib24","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1007\/s11010-013-1613-y","article-title":"Folate metabolite profiling of different cell types and embryos suggests variation in folate one-carbon metabolism, including developmental changes in human embryonic brain","volume":"378","author":"Leung","year":"2013","journal-title":"Mol Cell Biochem"},{"key":"10.1016\/j.ebiom.2023.104762_bib25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-2202-14-37","article-title":"Improving basic and translational science by accounting for litter-to-litter variation in animal models","volume":"14","author":"Lazic","year":"2013","journal-title":"BMC Neurosci"},{"issue":"Suppl 3","key":"10.1016\/j.ebiom.2023.104762_bib26","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1046\/j.1528-1157.44.s3.5.x","article-title":"Pathobiology and genetics of neural tube defects","volume":"44","author":"Finnell","year":"2003","journal-title":"Epilepsia"},{"key":"10.1016\/j.ebiom.2023.104762_bib27","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s003830000497","article-title":"Limb-body wall complex: a compound anomaly pattern in body-wall defects","volume":"17","author":"Pumberger","year":"2001","journal-title":"Pediatr Surg Int"},{"key":"10.1016\/j.ebiom.2023.104762_bib28","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/S0140-6736(81)90650-4","article-title":"The methyl folate trap. A physiological response in man to prevent methyl group deficiency in kwashiorkor (methionine deficiency) and an explanation for folic-acid induced exacerbation of subacute combined degeneration in pernicious anaemia","volume":"2","author":"Scott","year":"1981","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2023.104762_bib29","first-page":"888","article-title":"Folate deficiency alone does not produce neural tube defects in mice","volume":"122","author":"Heid","year":"1992","journal-title":"J\u00a0Nutr"},{"key":"10.1016\/j.ebiom.2023.104762_bib30","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/tera.10040","article-title":"Investigation of the effects of folate deficiency on embryonic development through the establishment of a folate deficient mouse model","volume":"65","author":"Burgoon","year":"2002","journal-title":"Teratology"},{"key":"10.1016\/j.ebiom.2023.104762_bib31","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1017\/S0007114520001178","article-title":"Maternal use of folic acid and multivitamin supplements and infant risk of birth defects in Norway, 1999-2013","volume":"124","author":"Gildestad","year":"2020","journal-title":"Br J Nutr"},{"key":"10.1016\/j.ebiom.2023.104762_bib32","doi-asserted-by":"crossref","first-page":"8420","DOI":"10.1016\/j.bmc.2006.08.043","article-title":"A\u00a0platform for designing HIV integrase inhibitors. Part 2: a two-metal binding model as a potential mechanism of HIV integrase inhibitors","volume":"14","author":"Kawasuji","year":"2006","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/j.ebiom.2023.104762_bib33","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1002\/cmdc.200900166","article-title":"Induced-fit docking approach provides insight into the binding mode and mechanism of action of HIV-1 integrase inhibitors","volume":"4","author":"Barreca","year":"2009","journal-title":"ChemMedChem"},{"key":"10.1016\/j.ebiom.2023.104762_bib34","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1515\/JPM.2007.056","article-title":"Justifying the \u2018Folate trap\u2019 in folic acid fortification programs","volume":"35","author":"Mahajan","year":"2007","journal-title":"J\u00a0Perinat Med"},{"key":"10.1016\/j.ebiom.2023.104762_bib35","doi-asserted-by":"crossref","first-page":"147","DOI":"10.5501\/wjv.v4.i2.147","article-title":"Elevated homocysteine levels in human immunodeficiency virus-infected patients under antiretroviral therapy: a meta-analysis","volume":"4","author":"Deminice","year":"2015","journal-title":"World J Virol"},{"key":"10.1016\/j.ebiom.2023.104762_bib36","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1093\/toxsci\/kfab112","article-title":"Dolutegravir impairs stem cell-based 3D morphogenesis models in a manner dependent on dose and timing of exposure: an implication for its developmental toxicity","volume":"184","author":"Kirkwood-Johnson","year":"2021","journal-title":"Toxicol Sci"},{"key":"10.1016\/j.ebiom.2023.104762_bib37","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1038\/s41598-018-21019-3","article-title":"Plasma homocysteine concentrations and risk of intracerebral hemorrhage: a systematic review and meta-analysis","volume":"8","author":"Zhou","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.ebiom.2023.104762_bib38","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.2174\/1381612823666170317124913","article-title":"Homocysteine and\u00a0non-cardiac vascular disease","volume":"23","author":"Katsiki","year":"2017","journal-title":"Curr Pharm Des"},{"key":"10.1016\/j.ebiom.2023.104762_bib39","doi-asserted-by":"crossref","first-page":"5703","DOI":"10.1007\/s12035-021-02508-5","article-title":"Dolutegravir inhibition of matrix metalloproteinases affects mouse neurodevelopment","volume":"58","author":"Bade","year":"2021","journal-title":"Mol Neurobiol"},{"key":"10.1016\/j.ebiom.2023.104762_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/ftox.2023.1113032","article-title":"Inhibition of matrix metalloproteinases by HIV-1 integrase strand transfer inhibitors","volume":"5","author":"Foster","year":"2023","journal-title":"Front Toxicol"},{"key":"10.1016\/j.ebiom.2023.104762_bib41","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.isci.2019.05.027","article-title":"Degradation of extracellular matrix by matrix metalloproteinase 2 is essential for the establishment of the blood-brain barrier in Drosophila","volume":"16","author":"Kanda","year":"2019","journal-title":"iScience"},{"key":"10.1016\/j.ebiom.2023.104762_bib42","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1038\/nrm2125","article-title":"Matrix metalloproteinases and the regulation of tissue remodelling","volume":"8","author":"Page-McCaw","year":"2007","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/j.ebiom.2023.104762_bib43","doi-asserted-by":"crossref","DOI":"10.1111\/mcn.13064","article-title":"Maternal folate, one-carbon metabolism and pregnancy outcomes","volume":"17","author":"Jankovic-Karasoulos","year":"2021","journal-title":"Matern Child Nutr"},{"key":"10.1016\/j.ebiom.2023.104762_bib44","article-title":"Maternal weight and birth outcomes among women on antiretroviral treatment from conception in a birth surveillance study in Botswana","volume":"24","author":"Zash","year":"2021","journal-title":"J\u00a0Int AIDS Soc"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423003286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396423003286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T19:31:31Z","timestamp":1762457491000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396423003286"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9]]},"references-count":44,"alternative-id":["S2352396423003286"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104762","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Folate deficiency increases the incidence of dolutegravir-associated foetal defects in a mouse pregnancy model","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2023.104762","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"104762"}}